toxicity management
Meeting the Toxicity Challenge Posed by Antibody–Drug Conjugates
Antibody–drug conjugates have yielded improved survival rates in patients with gynecologic malignancies, but ...
JULY 4, 2025
mTOR Inhibitor AEs May Be Surrogate Markers of Treatment Efficacy
Patients with metastatic renal cell carcinoma (mRCC) who experience more—and more severe—toxicities ...
JANUARY 16, 2017
Immunotherapy Ushers in New Era of Toxicity Management
Immunotherapy is becoming an integral player in cancer treatment, and with so many products in clinical trials, ...
OCTOBER 6, 2016
Load more